Opus Genetics, Inc. (IRD)
4.555
+0.10
(+2.36%)
USD |
NASDAQ |
Sep 03, 12:54
Opus Genetics 1 Year Total Returns (Daily) : 261.8% for Sept. 2, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 02, 2026 | 261.8% |
| September 01, 2026 | 213.9% |
| August 31, 2026 | 196.7% |
| August 28, 2026 | 210.1% |
| August 27, 2026 | 220.8% |
| August 26, 2026 | 215.4% |
| August 25, 2026 | 257.4% |
| August 24, 2026 | 250.4% |
| August 21, 2026 | 253.7% |
| August 20, 2026 | 255.2% |
| August 19, 2026 | 266.7% |
| August 18, 2026 | 220.9% |
| August 17, 2026 | 204.2% |
| August 14, 2026 | 205.9% |
| August 13, 2026 | 238.2% |
| August 12, 2026 | 238.7% |
| August 11, 2026 | 266.0% |
| August 10, 2026 | 242.1% |
| August 07, 2026 | 235.8% |
| August 06, 2026 | 238.2% |
| August 05, 2026 | 240.5% |
| August 04, 2026 | 243.5% |
| August 03, 2026 | 240.2% |
| July 31, 2026 | 234.2% |
| July 30, 2026 | 252.3% |
| Date | Value |
|---|---|
| July 29, 2026 | 204.4% |
| July 28, 2026 | 184.2% |
| July 27, 2026 | 183.9% |
| July 24, 2026 | 154.5% |
| July 23, 2026 | 143.3% |
| July 22, 2026 | 150.0% |
| July 21, 2026 | 157.1% |
| July 20, 2026 | 169.9% |
| July 17, 2026 | 180.7% |
| July 16, 2026 | 192.9% |
| July 15, 2026 | 216.4% |
| July 14, 2026 | 220.7% |
| July 13, 2026 | 237.2% |
| July 10, 2026 | 250.0% |
| July 09, 2026 | 262.2% |
| July 08, 2026 | 286.8% |
| July 07, 2026 | 308.2% |
| July 06, 2026 | 307.0% |
| July 02, 2026 | 327.3% |
| July 01, 2026 | 344.7% |
| June 30, 2026 | 336.3% |
| June 29, 2026 | 315.7% |
| June 26, 2026 | 292.2% |
| June 25, 2026 | 283.4% |
| June 24, 2026 | 301.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Perspective Therapeutics, Inc. | -6.63% |
| Praxis Precision Medicines, Inc. | 695.5% |
| Faeth Therapeutics, Inc. | 398.3% |
| Jade Biosciences, Inc. | 180.8% |
| ACADIA Pharmaceuticals, Inc. | 12.61% |